Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

about

Recombination of a dual-CAR-modified T lymphocyte to accurately eliminate pancreatic malignancy

Item

http://www.wikidata.org/entity/Q58786421

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@en

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@nl

type

Item

label

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@en

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@nl

prefLabel

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@en

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@nl

P1476

Recombination of a dual-CAR-mo ...... liminate pancreatic malignancy

@en

P2093

Chen Liu

http://www.w3.org/2001/XMLSchema#string

Erhao Zhang

http://www.w3.org/2001/XMLSchema#string

Hanmei Xu

http://www.w3.org/2001/XMLSchema#string

Heming Wu

http://www.w3.org/2001/XMLSchema#string

Jialiang Hu

http://www.w3.org/2001/XMLSchema#string

Jianpeng Xue

http://www.w3.org/2001/XMLSchema#string

Jieyi Gu

http://www.w3.org/2001/XMLSchema#string

Peiwei Yang

http://www.w3.org/2001/XMLSchema#string

Qingbo Sun

http://www.w3.org/2001/XMLSchema#string

Shengnan Zhang

http://www.w3.org/2001/XMLSchema#string

P2860

Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia

Mesothelin-Targeted CARs: Driving T Cells to Solid Tumors

Current status and progress of pancreatic cancer in China

Remote control of therapeutic T cells through a small molecule-gated chimeric receptor.

Chimeric antigen receptor T cells for sustained remissions in leukemia

Efficacy and toxicity management of 19-28z CAR T cell therapy in B cell acute lymphoblastic leukemia

Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

B-cell depletion and remissions of malignancy along with cytokine-associated toxicity in a clinical trial of anti-CD19 chimeric-antigen-receptor-transduced T cells

Pancreatic cancer

Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults

P2888

s13045-018-0646-9

P304

102

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13045-018-0646-9

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106141305

http://www.w3.org/2001/XMLSchema#string

P698

30103775

http://www.w3.org/2001/XMLSchema#string

P921

hematology

cancer research

molecular biology

P932

6090669

http://www.w3.org/2001/XMLSchema#string